Federal Register / Vol. 79, No. 70 / Friday, April 11, 2014 / Notices 20209 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

[CDC–2014–0006, Docket Number NIOSH– 

273] 

Notice of Draft Document for Public 

Comment 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of draft document for 

public comment. 

SUMMARY: The National Institute for 

Occupational Safety and Health of the 

Centers for Disease Control and 

Prevention announces the availability of 

a draft method to be published in the 

NIOSH Manual of Analytical Methods 

(NMAM) entitled ‘‘Method 8324: 3- 

Bromopropionic acid in urine; A 

metabolite of 1-bromopropane’’ now 

available for public comment. To view 

the notice and related materials, visit 

http://www.regulations.gov and enter 

CDC–2014–0006 in the search field and 

click ‘‘Search.’’ 

Public comment period: Comments 

must be received June 10, 2014. 

ADDRESSES: You may submit comments, 

identified by CDC–2014–0006 and 

Docket Number NIOSH–273, by either 

of the following two methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov Follow the 

instructions for submitting comments. 

• Mail: NIOSH Docket Office, Robert 

A. Taft Laboratories, 4676 Columbia 

Parkway, MS C–34, Cincinnati, Ohio 

45226. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

[CDC–2014–0006; NIOSH–273]. All 

relevant comments received will be 

posted without change http://

www.regulations.gov, including any 

personal information provided. All 

information received in response to this 

notice will also be available for public 

examination and copying at the NIOSH 

Docket Office, 4676 Columbia Parkway, 

Room 109, Cincinnati, OH 45226. 

SUPPLEMENTARY INFORMATION: 

Background: The NIOSH Manual of 

Analytical Methods (NMAM) was first 

published in 1974 and currently 

contains over 300 methods that can be 

used by the occupational safety and 

health community to measure worker 

exposures. 1-Bromopropane is an 

industrial solvent often used as a 

substitute for a number of 

chlorofluorocarbon solvents which were 

withdrawn from use because of their 

possible damaging effects to the ozone 

layer. 3-Bromopropionic acid is a 

human metabolite of 1-bromopropane 

and a proposed biomarker of exposure. 

An accurate and precise method was 

developed for the detection and 

quantitation of 3-bromopropionic acid 

in human urine. This method was 

published in the literature (B’Hymer CB, 

Cheever KL [2004]. J Chromatogr B 

802:361–366). The method was 

validated by a second laboratory and is 

proposed for inclusion in NMAM’s 5th 

Edition. 

FOR FURTHER INFORMATION CONTACT: Dale 

Shoemaker, Ph.D., NIOSH DART, 4676 

Columbia Parkway MS R–7, Cincinnati, 

OH 45226. (513) 841–4523. 

Dated: April 7, 2014. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–08141 Filed 4–10–14; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), National 

Center for Health Statistics (NCHS) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 11:00 a.m.–5:30 p.m., 

May 12, 2014, 8:30 a.m.–1:00 p.m., May 13, 

2014 

Place: NCHS Headquarters, 3311 Toledo 

Road, Hyattsville, Maryland 20782. 

Status: This meeting is open to the public; 

however, visitors must be processed in 

accordance with established federal policies 

and procedures. For foreign nationals or nonUS citizens, pre-approval is required (please 

contact Gwen Mustaf, 301–458–4500, glm4@

cdc.gov, or Virginia Cain, vcain@cdc.gov at 

least 10 days in advance for requirements). 

All visitors are required to present a valid 

form of picture identification issued by a 

state, federal or international government. As 

required by the Federal Property 

Management Regulations, Title 41, Code of 

Federal Regulation, Subpart 101–20.301, all 

persons entering in or on Federal controlled 

property and their packages, briefcases, and 

other containers in their immediate 

possession are subject to being x-rayed and 

inspected. Federal law prohibits the knowing 

possession or the causing to be present of 

firearms, explosives and other dangerous 

weapons and illegal substances. The meeting 

room accommodates approximately 100 

people. 

Purpose: This committee is charged with 

providing advice and making 

recommendations to the Secretary, 

Department of Health and Human Services; 

the Director, CDC; and the Director, NCHS, 

regarding the scientific and technical 

program goals and objectives, strategies, and 

priorities of NCHS. 

Matters For Discussion: The agenda will 

include welcome remarks by the Director, 

NCHS; the March 4–5, 2014 Office of 

Analysis and Epidemiology Program Review; 

report from the February 10–11, 2014 

National Academy of Sciences Workshop on 

Guidelines for Returning Individual Results 

from Genome Research Using PopulationBased Specimens; program updates. 

Requests to make oral presentations should 

be submitted in writing to the contact person 

listed below. All requests must contain the 

name, address, telephone number, and 

organizational affiliation of the presenter. 

Written comments should not exceed five 

single-spaced typed pages in length and must 

be received by April 25, 2014. 

The agenda items are subject to change as 

priorities dictate. 

Contact Person For More Information: 

Virginia S. Cain, Ph.D., Director of 

Extramural Research, NCHS/CDC, 3311 

Toledo Road, Room 7208, Hyattsville, 

Maryland 20782, telephone (301) 458–4500, 

fax (301) 458–4020. The Director, 

Management Analysis and Services Office, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities for both the 

Centers for Disease Control and the Agency 

for Toxic Substances and Disease Registry. 

Gary J. Johnson, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–08199 Filed 4–10–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–37, CMS–64, 

CMS–10320, CMS–10396, CMS–102 and 

CMS–105, and CMS–367] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 


tkelley on DSK3SPTVN1PROD with NOTICES